Comprehensive Solutions for DOAC Research from Diapharma

Posted: November 14, 2019

DIKI, DILI, NASH, NAFLD, ALD/AHDOAC

COUNT ON DIAPHARMA

Anticoagulation Measurement
Your resource for DOAC / NOAC research in areas such as:
  • Renal insufficiency
  • Malignancy
  • Heparin-Induced Thrombocytopenia (HIT)
  • Antiphospholipid syndrome (APS)
  • Ehlers-Danlos syndrome
  • New indications for DOACs
  • DOAC reversal agent development

 

DOAC

Diapharma offers the latest tools for novel anticoagulation research

DOAC Calibrators & Controls

Apixaban ● Rivaroxaban ● Edoxaban ● Arixtra ● Dabigatran

Ceveron alpha TGA

Walk-away TGA for studying potential new anticoagulants

Technochrom anti-Xa

Chromogenic anti-Xa kit for accurate DOAC measurement

Technoclone DTI

Modified Thrombin Time for DTI studies

 

RESEARCH USE ONLY IN THE U.S. AND CANADA

 

DOAC

RESEARCH USE ONLY

IN THE U.S. AND CANADA

And ask us about

DOAC-STOP™

Tablets

The first product to effectively remove DOACs from plasma

Simplify your testing and get accurate results

Perform clotting assays on plasma containing DOACs in anticoagulant research

doac

K18 Liver Injury Biomarker hepatotoxicity rat

ML-00-00524Rev01